Literature DB >> 12813031

Analysis of p53 "latency" and "activation" by fluorescence correlation spectroscopy. Evidence for different modes of high affinity DNA binding.

Julian Wölcke1, Maurice Reimann, Martin Klumpp, Thomas Göhler, Ella Kim, Wolfgang Deppert.   

Abstract

The concept that the tumor suppressor p53 is a latent DNA-binding protein that must become activated for sequence-specific DNA binding recently has been challenged, although the "activation" phenomenon has been well established in in vitro DNA binding assays. Using electrophoretic mobility shift assays and fluorescence correlation spectroscopy, we analyzed the binding of "latent" and "activated" p53 to double-stranded DNA oligonucleotides containing or not containing a p53 consensus binding site (DNAspec or DNAunspec, respectively). In the absence of competitor DNA, latent p53 bound DNAspec and DNAunspec with high affinity in a sequence-independent manner. Activation of p53 by the addition of the C-terminal antibody PAb421 significantly decreased the binding affinity for DNAunspec and concomitantly increased the binding affinity for DNAspec. The net result of this dual effect is a significant difference in the affinity of activated p53 for DNAspec and DNAunspec, which explains the activation of p53. High affinity nonspecific DNA binding of latent p53 required both the p53 core domain and the p53 C terminus, whereas high affinity sequence-specific DNA binding of activated p53 was mediated by the p53 core domain alone. The data suggest that high affinity nonspecific DNA binding of latent and high affinity sequence-specific binding of activated p53 to double-stranded DNA differ in their requirement for the C terminus and involve different structural features of the core domain. Because high affinity nonspecific DNA binding of latent p53 is restricted to wild type p53, we propose that it relates to its tumor suppressor functions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12813031     DOI: 10.1074/jbc.M303615200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  The DNA binding activity of p53 displays reaction-diffusion kinetics.

Authors:  Peter Hinow; Carl E Rogers; Christopher E Barbieri; Jennifer A Pietenpol; Anne K Kenworthy; Emmanuele DiBenedetto
Journal:  Biophys J       Date:  2006-04-07       Impact factor: 4.033

2.  Fluorescence correlation spectroscopy of the binding of nucleotide excision repair protein XPC-hHr23B with DNA substrates.

Authors:  Y Roche; D Zhang; G M J Segers-Nolten; W Vermeulen; C Wyman; K Sugasawa; J Hoeijmakers; C Otto
Journal:  J Fluoresc       Date:  2008-06-24       Impact factor: 2.217

3.  Reversal of 5-flouroucial resistance by adenovirus-mediated transfer of wild-type p53 gene in multidrug-resistant human colon carcinoma LoVo/5-FU cells.

Authors:  Zhi-Wei Yu; Peng Zhao; Ming Liu; Xin-Shu Dong; Ji Tao; Xue-Qin Yao; Xin-Hua Yin; Yu Li; Song-Bin Fu
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

4.  Protein-protein interaction analysis by C-terminally specific fluorescence labeling and fluorescence cross-correlation spectroscopy.

Authors:  Rieko Oyama; Hideaki Takashima; Masato Yonezawa; Nobuhide Doi; Etsuko Miyamoto-Sato; Masataka Kinjo; Hiroshi Yanagawa
Journal:  Nucleic Acids Res       Date:  2006-08-16       Impact factor: 16.971

5.  Mutant p53 proteins bind DNA in a DNA structure-selective mode.

Authors:  Thomas Göhler; Stefan Jäger; Gabriele Warnecke; Hideyo Yasuda; Ella Kim; Wolfgang Deppert
Journal:  Nucleic Acids Res       Date:  2005-02-18       Impact factor: 16.971

6.  A rapid and high-throughput quantitation assay of the nuclear factor κB activity using fluorescence correlation spectroscopy in the setting of clinical laboratories.

Authors:  Kenu Harada; Shintaro Mikuni; Hideyuki Beppu; Hideki Niimi; Shigeki Abe; Nobuko Hano; Koichi Yamagata; Masataka Kinjo; Isao Kitajima
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.